Havelka has more than 25 year of experience in leadership roles at multinational specialty chemical and industrial products organizations. She joins Angus from Fuchs Lubricants Company where she most recently served as senior director of R&D and quality control.
Havelka succeeds David Green, Ph.D., who will retire at the end of April 2021 after 25 years of service with the company.
The announcement was made by Angus president and CEO David Neuberger, to whom Havelka will report.
Neuberger said, Kathleen has an impressive track record of leading innovation, driving the introduction of new technologies, fostering collaboration and finding improved technical solutions to support growth. She brings a deep understanding of the strategic end markets we serve, as well as the diversified needs of our customers around the world. I look forward to the addition of Kathleen s experience and scientific expertise to the Angus Leadership Team.
Share this article
Share this article
BUFFALO GROVE, Ill., April 22, 2021 /PRNewswire/ ANGUS Chemical Company ( ANGUS or Company ), a leading global manufacturer and marketer of specialty chemicals for Life Sciences and Industrial markets, today announced the appointment of Dr. Kathleen Havelka as Vice President of Research and Development (R&D). The announcement was made by ANGUS President and CEO David Neuberger, to whom Dr. Havelka will report.
Dr. Havelka is a chemical industry veteran with more than 25 years experience in numerous leadership roles in multinational specialty chemical and industrial products organizations. She joins ANGUS from Fuchs Lubricants Company where she most recently served as Senior Director of R&D and Quality Control. Prior to Fuchs, she held significant roles in R&D, sales and marketing at Elevance Renewable Sciences, Diversey (Johnson-Diversey) and Lubrizol Corporation.